April 1 (Reuters) - Recce Pharmaceuticals Ltd RCE.AX :
* DATA SHOWING POSITIVE EFFICACY OF A NEW ANTI-INFECTIVE FORMULATION RECCE 111 AGAINST S. PNEUMONIAE BACTERIAL SINUSITIS IN MICE
April 1 (Reuters) - Recce Pharmaceuticals Ltd RCE.AX :
* DATA SHOWING POSITIVE EFFICACY OF A NEW ANTI-INFECTIVE FORMULATION RECCE 111 AGAINST S. PNEUMONIAE BACTERIAL SINUSITIS IN MICE